𝔖 Bobbio Scriptorium
✦   LIBER   ✦

All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy

✍ Scribed by N. Asou; Koichi Adachi; Jun-ichi Tamura; Akihisa Kanamaru; Shin-ichi Kageyama; Akira Hiraoka; Eijiro Omoto; Hisashi Sakamaki; Kazuo Tsubaki; Kenji Saito; Ryuzo Ohno

Publisher
Springer
Year
1997
Tongue
English
Weight
130 KB
Volume
40
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Significant reduction of medical costs b
Significant reduction of medical costs by differentiation therapy with all-trans retinoic acid during remission induction of newly diagnosed patients with acute promyelocytic leukemia
✍ Akihiro Takeshita; Hisashi Sakamaki; Shuichi Miyawaki; Toru Kobayashi; Kazutaka πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 631 KB

Background. Differentiation therapy with all-trans retinoic acid (RA) induces more than 80% complete remission with the least complications in patients with acute promyelocytic leukemia (APL). The authors studied the cost-benefit of this new treatment modality compared with conventional chemotherapy

Acute promyelocytic leukemia: All-trans
Acute promyelocytic leukemia: All-trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA alone
✍ Advani, Suresh H.; Nair, Reena; Bapna, Ajay; Gladstone, Betty; Kadam, Pratibha; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 61 KB πŸ‘ 2 views

This study was conducted to compare the results of treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid alone (ATRA) or a combination therapy of ATRA followed by chemotherapy. Forty-three patients treated between February 1992 and February 1996 were included in this study. Ei

All-trans retinoic acid followed by chem
All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia
✍ Jorge E. Cortes; Hagop Kantarjian; Susan O'Brien; L. E. Robertson; Charles Kolle πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 599 KB

Background. All-trans retinoic acid (ATRA) is effective in the treatment of relapsed or refractory acute promyelocytic leukemia (APL), but relapse is the rule if response is unmaintained. Methods. Seventeen patients with APL were salvaged with ATRA at a dosage of 50 mg/mz/day for 3 months or until